Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation
- PMID: 2394828
- PMCID: PMC296788
- DOI: 10.1172/JCI114770
Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation
Abstract
Familial lipoprotein lipase (LPL) deficiency is a rare genetic disorder accompanied by well-characterized manifestations. The phenotypic expression of heterozygous LPL deficiency has not been so clearly defined. We studied the pedigree of a proband known to be homozygous for a mutation resulting in nonfunctional LPL. Hybridization of DNA from 126 members with allele-specific probes detected 29 carriers of the mutant allele. Adipose tissue LPL activity, measured previously, was reduced by 50% in carriers, but did not reliably distinguish them from noncarriers. Carriers were prone to the expression of a form of familial hypertriglyceridemia characterized by increased plasma triglyceride, VLDL cholesterol and apolipoprotein B, and decreased LDL and HDL cholesterol concentrations. These manifestations were age modulated, with conspicuous differences between carriers and noncarriers observed only after age 40. Several noncarriers exhibited similar lipid abnormalities, but without the inverse relationship between VLDL cholesterol and LDL cholesterol noted among carriers. In addition to age and carrier status, the potentially reversible conditions, obesity, hyperinsulinemia and lipid-raising drug use were contributory. Thus heterozygous lipoprotein lipase deficiency, together with age-related influences, may account for a form of familial hypertriglyceridemia.
Similar articles
-
Hyperinsulinemia and abdominal obesity affect the expression of hypertriglyceridemia in heterozygous familial lipoprotein lipase deficiency.Diabetes. 1997 Dec;46(12):2063-8. doi: 10.2337/diab.46.12.2063. Diabetes. 1997. PMID: 9392497
-
Severe hypercholesterolemia in a double heterozygote for lipoprotein lipase deficiency (LPL(Arita)) and apolipoprotein epsilon4: a report of a family with LPL(Arita).Endocr J. 2001 Feb;48(1):113-8. doi: 10.1507/endocrj.48.113. Endocr J. 2001. PMID: 11403097
-
Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities.J Clin Invest. 1993 Feb;91(2):448-55. doi: 10.1172/JCI116222. J Clin Invest. 1993. PMID: 8432854 Free PMC article.
-
[Physiology and pathophysiology of the metabolism of lipoproteins].Wien Med Wochenschr. 1994;144(12-13):286-90. Wien Med Wochenschr. 1994. PMID: 8650930 Review. German.
-
Molecular genetics of human lipoprotein lipase deficiency.Mol Cell Biochem. 1992 Aug 18;113(2):171-6. doi: 10.1007/BF00231536. Mol Cell Biochem. 1992. PMID: 1518507 Review.
Cited by
-
The pathophysiology of intestinal lipoprotein production.Front Physiol. 2015 Mar 20;6:61. doi: 10.3389/fphys.2015.00061. eCollection 2015. Front Physiol. 2015. PMID: 25852563 Free PMC article. Review.
-
Linkage of low-density lipoprotein size to the lipoprotein lipase gene in heterozygous lipoprotein lipase deficiency.Am J Hum Genet. 1999 Feb;64(2):608-18. doi: 10.1086/302234. Am J Hum Genet. 1999. PMID: 9973300 Free PMC article.
-
Gene-environment interactions in atherosclerosis.Mol Cell Biochem. 1992 Aug 18;113(2):177-86. doi: 10.1007/BF00231537. Mol Cell Biochem. 1992. PMID: 1325605 Review.
-
Mutations in exon 3 of the lipoprotein lipase gene segregating in a family with hypertriglyceridemia, pancreatitis, and non-insulin-dependent diabetes.J Clin Invest. 1993 Jul;92(1):203-11. doi: 10.1172/JCI116551. J Clin Invest. 1993. PMID: 8325986 Free PMC article.
-
Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia.Nat Rev Cardiol. 2022 Sep;19(9):577-592. doi: 10.1038/s41569-022-00676-y. Epub 2022 Mar 22. Nat Rev Cardiol. 2022. PMID: 35318466 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical